Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Brian Necela"'
Autor:
Emmanuel M. Gabriel, Brian Necela, Deborah Bahr, Sneha Vivekanandhan, Barath Shreeder, Sanjay Bagaria, Keith L. Knutson
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract In this study, we tested a novel approach of “repurposing” a biomarker typically associated with breast cancer for use in melanoma. HER2/neu is a well characterized biomarker in breast cancer for which effective anti-HER2/neu therapies a
Externí odkaz:
https://doaj.org/article/15cf9697167549baa914c2e9e20348c7
Autor:
Yi Lin, Yan W Asmann, Barath Shreeder, Keith L Knutson, Erik Jessen, Daniel P Wickland, Colton McNinch, Brian Necela
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 5 (2024)
Background Cancer neoantigens arise from protein-altering somatic mutations in tumor and rank among the most promising next-generation immuno-oncology agents when used in combination with immune checkpoint inhibitors. We previously developed a comput
Externí odkaz:
https://doaj.org/article/bf5610643ea74733ae707eb219999a5b
Autor:
Peter Storz, David W. Dawson, Lizhi Zhang, Brandy Edenfield, Brian Necela, Heike Döppler, Geou-Yarh Liou
Supplementary Figure S3 shows analysis for microvascularization (A), alcian blue staining of tissue sections (B), and ICAM-1 expression in human samples (C).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12a73fb173f17e77a8bc3f2449e01f3c
https://doi.org/10.1158/2159-8290.22530177.v1
https://doi.org/10.1158/2159-8290.22530177.v1
Autor:
Peter Storz, David W. Dawson, Lizhi Zhang, Brandy Edenfield, Brian Necela, Heike Döppler, Geou-Yarh Liou
Desmoplasia and an inflammatory environment are defining features of pancreatic cancer. Unclear is how pancreatic cells that undergo oncogenic transformation can cross-talk with immune cells and how this contributes to the development of pancreatic l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd46ad8072666f3a666a670952d43110
https://doi.org/10.1158/2159-8290.c.6546120
https://doi.org/10.1158/2159-8290.c.6546120
Autor:
Emmanuel M. Gabriel, Brian Necela, Deborah Bahr, Jamie Kaplan, Kristopher Attwood, Keith Knutson
Publikováno v:
Cancer Research. 82:5371-5371
INTRODUCTION: HER2/neu is a potent biomarker for which anti-HER2/neu antibodies offer significant responses. However, many cancers, such as melanoma, have less than 5% expression of HER2/neu. The purpose of this study was to determine whether induced